Founded in 1869, the Second Affiliated Hospital Zhejiang University School of Medicine (SAHZU) was considered the cradle of western medicine in Zhejiang province. The hospital now owns several top-notch innovation and research platforms on nation level: Transvascular Implantable Devices Key Laboratory, National Emergency Medical Rescue Center, Key Laboratory Early Warning and Intervention of Malignant Tumor and Multi-organ Failure, Ministry of Education, etc. As of 2021, SAHZU has 8 campuses with almost four thousand beds and more than seven thousand staff, including three thousand physicians and three thousand nurses in 56 clinical departments, many of which are national key clinical departments or disciplines approved by the National Health Commission. SAHZU has become the role model for Chinese hospitals in the field of transcatheter valve intervention, the micro-incision cataract surgery, colorectal cancer, pediatric kidney implantation and severe burns. With more than 7 million outpatient and emergency visits, 260,000 inpatient admissions, and almost 200,000 operations every year, SAHZU is one of the most efficient tertiary public hospitals in China. The hospital is also widely recognized as the pioneer of "Internet+Medicine" care model and the trend-setter of medical assistance to other less developed areas in China.